Related Experiment Videos
Hematopoietic stem cell transplantation in rheumatic diseases
1Department of Haematology, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Current Opinion in Rheumatology
|May 18, 1999
Summary
Hematopoietic stem cell transplantation (HSCT) is increasingly used for severe autoimmune diseases. This review covers recent advances in HSCT for inflammatory rheumatic diseases and future research directions.
Area of Science:
- Immunology
- Rheumatology
- Hematology
Background:
- Hematopoietic stem cell transplantation (HSCT) shows promise for treating autoimmune diseases, initially based on animal studies and case reports.
- Recent advancements in autologous HSCT, particularly using cytokine-mobilized peripheral blood stem cells, have led to its application in severe autoimmune and inflammatory conditions.
Purpose of the Study:
- To review the literature on HSCT for inflammatory rheumatic diseases.
- To discuss future strategies for optimizing HSCT as a treatment for these conditions.
Main Methods:
- Literature review of studies on HSCT for inflammatory rheumatic diseases.
- Analysis of data from the International Autoimmune Disease Stem Cell Project Database (150 cases by March 1999).
Main Results:
- HSCT is being specifically used for severe autoimmune and inflammatory diseases.
- Guidelines for HSCT in autoimmune diseases have been established.
- A significant number of cases (150 by March 1999) have been registered for autoimmune disease treatment.
Conclusions:
- HSCT is an evolving intensive treatment approach for severe autoimmune and inflammatory rheumatic diseases.
- Further research is needed to refine HSCT protocols for better patient outcomes.